Company: NCEL
Filing Date: 2025-05-16
Form Type: 20-F
Source: 0001213900-25-044868
Chunk: 374

Company: NewcelX Ltd.
Filing Date: 2025-05-16
Form: 20-F
Item: Item 19
Chunk 374
---
 2024. Investors also received unregistered warrants to purchase up to81,944Company Common Shares at an exercise
price of $9.60per share. These warrants are exercisable upon issuance and will expire five years from the date of issuance.
The offering resulted in gross proceeds of $786,660. The net proceeds were used for working capital and general corporate purposes.

H. C. Wainwright & Co., LLC served as the
exclusive placement agent for the offering, or the Placement Agent. The Company agreed to pay the Placement Agent a cash fee of7.0%
of the gross proceeds, a management fee of1.0% of the gross proceeds, and $50,000for accountable expenses. Additionally,
the Company issued to the Placement Agent warrants to purchase up to5,736Company Common Shares at an exercise price of $12.00per
share. These warrants are exercisable from the date of issuance until five years from the commencement of sales in the offering.

On March 20, 2024, the Company entered into a
securities purchase agreement, or the Purchase Agreement, providing for the issuance in a registered direct offering of175,000Company
Common Shares at a purchase price of $10.00per share that closed on March 22, 2024. In addition, pursuant to the Purchase Agreement,
the investors received unregistered warrants, or the Common Warrants, to purchase up to an aggregate of87,500Company Common Shares
at an exercise of $10.00per share in a concurrent private placement. The Common Warrants were immediately exercisable upon issuance
and will expire five years following the date of issuance. The Company has also agreed that from the date of the Purchase Agreement until
one year after the closing date of the offering, the Company shall not enter into an agreement to effect any issuance by the Company
or any of the Company’s subsidiaries of Company Common Shares or common share equivalents (or a combination of units thereof) involving
a variable rate transaction. The offering resulted in gross proceeds to the Company of $1,750,000and expenses of approximately $321,000.

Warrants

On October 9, 2024, the Company and certain existing
warrant holders entered into warrant amendment agreements, or collectively, the Amendment, to amend those warrants issued by Company to
such holders, collectively, to purchase up to105,843Common Shares issued to such holders, or the Existing Warrants. The Amendment makes
certain adjustment to the definition